tiprankstipranks

Jack Khattar Insider Profile

4 Followers
Jack Khattar, President & CEO, Director at Supernus Pharmaceuticals, holds 2.22M shares in Supernus Pharmaceuticals (Ticker: SUPN), holds 73.50K shares in Cognition Therapeutics (Ticker: CGTX), holds 0.00 shares in scPharmaceuticals (Ticker: SCPH).
tipranks
Jack Khattar

Jack Khattar
Supernus Pharmaceuticals (SUPN)
President & CEO, Director

Ranked #21,542 out of 108,921 Corporate Insiders

Profitable Transactions

75%
12 out of 16 Profitable Transactions

Average Return

+5.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$94M
99.92%
0.08%
A breakdown of Jack Khattar's holdings

Insider Roles

Supernus Pharmaceuticals
(SUPN)
President & CEO, Director
Cognition Therapeutics
(CGTX)
Director
Roles that Jack Khattar holds in companies

Most Profitable Insider Trade

Stock:
scPharmaceuticals
(SCPH)
Rating:Informative Buy
Date:Dec 06, 2021 - Dec 06, 2022
Return:+62.60%
The most profitable trade made by Jack Khattar

Jack Khattar's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Supernus Pharmaceuticals
Aug 14, 2026
President & CEO, Director
Uninformative Buy
801.33K
$94.04M
TSRO
Tesaro
Mar 30, 2016
Uninformative Sell
$115.47M
SCPH
scPharmaceuticals
Oct 07, 2025
Uninformative Sell
$0.00
Cognition Therapeutics
Jun 22, 2026
Director
Uninformative Buy
$74.23K
List of latest transactions for each holding click on a transaction to see Jack Khattar's performance on stock

Jack Khattar insider profile FAQ

What is the percentage of profitable transactions made by Jack Khattar?
The percentage of profitable transactions made by Jack Khattar is 75%.
    What is the average return per transaction made by Jack Khattar?
    The average return per transaction made by Jack Khattar is 5.00%.
      What stocks does Jack Khattar hold?
      Jack Khattar holds: SUPN, TSRO, SCPH, CGTX stocks.
        What was Jack Khattar’s latest transaction?
        Jack Khattar latest transaction was an Uninformative Buy of $801.33K.
          What was Jack Khattar's most profitable transaction?
          Jack Khattar’s most profitable transaction was an Informative Buy of SCPH stock on December 6, 2021. The return on the trade was 62.60%.
            What is Jack Khattar's role in Supernus Pharmaceuticals?
            Jack Khattar's role in Supernus Pharmaceuticals is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.